Search - tctmd.com

Displaying 161 - 180 of 788

Sort: Relevancy | Date

$Debate: Are We Really Ready for Phase III Trials? For Refractory Angina There Are Knowns and Unknowns!$

Presentation TCT 2015

Debate: Are We Really Ready for Phase III Trials? For Refractory Angina There Are Knowns and Unknowns!

Presenter: Francisco Fdez-Aviles, Timothy D. Henry

October 15, 2015

$Miscellaneous Emerging Technologies 2: The Neovasc Reducer System for Refractory Angina$

Presentation TCT 2015

Miscellaneous Emerging Technologies 2: The Neovasc Reducer System for Refractory Angina

Presenter: Greg L. Kaluza, Joachim Schofer, Timothy D. Henry

October 15, 2015

News Conference News TCT 2015

Initial Surgical AVR Improves Long-term Outcomes in Asymptomatic Patients With Severe AS

October 15, 2015

News Conference News TCT 2015

RIVER-PCI: No Advantage to Ranolazine in Patients With Incomplete Revascularization

Yael L. Maxwell

October 13, 2015

News Conference News TCT 2015

PLATFORM: FFRCT Reduces Costs Compared With Invasive Coronary Angiography

October 13, 2015

News Industry News

Medical Therapy With Ranolazine Did Not Reduce Adverse Events In Patients With Persistent Untreated Heart Artery Blockages After Percutaneous Coronary Intervention

October 13, 2015

News Conference News TCT 2015

CENTURY II: Bioresorbable-Polymer DES Safe, Effective at 2 Years

October 13, 2015

News Industry News

Assessing Fractional Flow Reserve Using Computed Tomography Shown To Reduce Costs in Patients With Chest Pain

October 13, 2015

News Conference News TCT 2015

ABSORB III: Novel Bioresorbable Scaffold as Good as Standard-of-Care DES

Yael L. Maxwell

October 12, 2015

News Industry News

ABSORB III: Clinical Trial Demonstrates That A Bioresorbable Scaffold Is Non-Inferior To A Drug-Eluting Stent In Patients With Coronary Artery Disease

October 12, 2015

Presentation TCT 2015

Case Presentation: Pretreatment A Patient With Class II Angina and Anterior Wall Ischemia

Presenter: Kevin J. Beatt, Craig R. Smith, Hemal Gada

October 11, 2015

Presentation TCT 2015

Stable Angina: PCI vs CABG vs OMT

Presenter: George D. Dangas, Robert T. Pyo

October 11, 2015

News Daily News

Revascularization May Benefit Stable CAD Patients With Unclassifiable Appropriateness Scores

Todd Neale

October 08, 2015

News Daily News

La Revascularización Podría Beneficiar a Pacientes con EAC Estable Con Puntuaciones Inclasificables de Conveniencia

Todd Neale

October 08, 2015

News Daily News

丹麦的一项研究揭示了NSTEMI、不稳定型心绞痛的治疗和结果的社会经济差距

Yael L. Maxwell

September 25, 2015

News Daily News

Un Estudio Danés Revela la Disparidad Socioeconómica en el Tratamiento y Resultados de los Cuadros de NSTEMI y Angina Inestable

Yael L. Maxwell

September 25, 2015

News Daily News

Danish Study Reveals Socioeconomic Disparity in Treatment, Outcomes for NSTEMI, Unstable Angina

Yael L. Maxwell

September 25, 2015

Presentation

Does Access to Invasive Examination and Treatment Influence Socioeconomic Differences in Case Fatality for Pts Admitted with NSTEMI or Unstable Angina?

Presenter: Solvej M?rtensson

September 24, 2015

News Daily News

与预期相反，研究发现冠状动脉微血管功能障碍无性别差异

Yael L. Maxwell

September 23, 2015

News Daily News

En Contra de lo que cabría Esperar, el Estudio No halla Diferencia de Género en la Disfunción Microvascular Coronaria

Yael L. Maxwell

September 23, 2015

Advertisement

Debate: Are We Really Ready for Phase III Trials? For Refractory Angina There Are Knowns and Unknowns!

Miscellaneous Emerging Technologies 2: The Neovasc Reducer System for Refractory Angina

Initial Surgical AVR Improves Long-term Outcomes in Asymptomatic Patients With Severe AS

RIVER-PCI: No Advantage to Ranolazine in Patients With Incomplete Revascularization

PLATFORM: FFRCT Reduces Costs Compared With Invasive Coronary Angiography

Medical Therapy With Ranolazine Did Not Reduce Adverse Events In Patients With Persistent Untreated Heart Artery Blockages After Percutaneous Coronary Intervention

CENTURY II: Bioresorbable-Polymer DES Safe, Effective at 2 Years

Assessing Fractional Flow Reserve Using Computed Tomography Shown To Reduce Costs in Patients With Chest Pain

ABSORB III: Novel Bioresorbable Scaffold as Good as Standard-of-Care DES

ABSORB III: Clinical Trial Demonstrates That A Bioresorbable Scaffold Is Non-Inferior To A Drug-Eluting Stent In Patients With Coronary Artery Disease

Case Presentation: Pretreatment A Patient With Class II Angina and Anterior Wall Ischemia

Stable Angina: PCI vs CABG vs OMT

Revascularization May Benefit Stable CAD Patients With Unclassifiable Appropriateness Scores

La Revascularización Podría Beneficiar a Pacientes con EAC Estable Con Puntuaciones Inclasificables de Conveniencia

丹麦的一项研究揭示了NSTEMI、不稳定型心绞痛的治疗和结果的社会经济差距

Un Estudio Danés Revela la Disparidad Socioeconómica en el Tratamiento y Resultados de los Cuadros de NSTEMI y Angina Inestable

Danish Study Reveals Socioeconomic Disparity in Treatment, Outcomes for NSTEMI, Unstable Angina

Does Access to Invasive Examination and Treatment Influence Socioeconomic Differences in Case Fatality for Pts Admitted with NSTEMI or Unstable Angina?

与预期相反，研究发现冠状动脉微血管功能障碍无性别差异

En Contra de lo que cabría Esperar, el Estudio No halla Diferencia de Género en la Disfunción Microvascular Coronaria

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content